awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41807279-B346D160-3355-4B0A-8100-910EB3817467
Q41807279-B346D160-3355-4B0A-8100-910EB3817467
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41807279-B346D160-3355-4B0A-8100-910EB3817467
Selective JAK2/ABL dual inhibition therapy effectively eliminates TKI-insensitive CML stem/progenitor cells.
P2860
Q41807279-B346D160-3355-4B0A-8100-910EB3817467
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41807279-B346D160-3355-4B0A-8100-910EB3817467
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dd891f69f57094da8d290210d49f12fc67164e3e
P2860
Specificity and mechanism-of-action of the JAK2 tyrosine kinase inhibitors ruxolitinib and SAR302503 (TG101348).